using our recently described model of acute lung injury in rats after systemic activation of complement by cobra venom factor ( cvf ) , we demonstrated that pretreatment of animals with human milk apolactoferrin ( in its native or derivatized form ) , but not iron-saturated lactoferrin , provides significant protection against complement- and neutrophil-mediated lung injury .
C0009528
activation
C0009498
complement